Parsec Financial Management Inc. Raises Position in Gilead Sciences, Inc. (GILD)

Ivan Schwartz
June 14, 2017

Abner Herrman & Brock LLC now owns 10,202 shares of the biopharmaceutical company's stock valued at $693,000 after buying an additional 50 shares during the period. About 201,544 shares traded. Leerink Swann initiated Gilead Sciences, Inc. It has underperformed by 15.45% the S&P500. Gilead Sciences now has $86.09 billion valuation. The stock declined 0.06% or $0.04 reaching $64.59 per share. Morgan Stanley (NYSE:MS) has risen 57.08% since June 14, 2016 and is uptrending. It has outperformed by 48.89% the S&P500. Investors of record on Friday, June 16th will be issued a $0.52 dividend. Its down 0.23, from 0.93 in 2016Q3. It is negative, as 106 investors sold Gilead Sciences, Inc. shares while 656 reduced holdings.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. 950.84 million shares or 0.69% more from 944.29 million shares in 2016Q3 were reported. Alpine Woods Investors Llc holds 31,600 shares or 0.13% of its portfolio. Adell Harriman Carpenter accumulated 38,215 shares. Shaker Invs Oh reported 14,836 shares. After $2.20 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -3.18% negative EPS growth. (NASDAQ:GILD) by 4.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Sullivan Bruyette Speros & Blaney LLC boosted its position in Gilead Sciences by 0.6% in the fourth quarter. (NASDAQ:GILD). Sol reported 6,525 shares. (NYSE:SE). Caprock Group holds 23,970 shares. SLB comes in with a P/S ratio of 3.42 that's greater than 1, potentially implying that it could be expensive relative to the overall sector (16.48) and its peers (4.66). (NASDAQ:GILD). Bright Rock Capital Mgmt Ltd Limited Liability Company has 2.35% invested in Gilead Sciences, Inc. Atria Ltd Liability Corp owns 0.16% invested in Gilead Sciences, Inc. Teacher Retirement Of Texas reported 1.24M shares. Glenmede Trust Company Na holds 359,653 shares.

Gilead Sciences (NASDAQ:GILD) last released its quarterly earnings data on Tuesday, May 2nd. Therefore 56% are positive. Lombard Odier Transatlantic Limited Partnership increased its stake in Gilead Sciences by 55.6% in the third quarter. (NASDAQ:GILD) has "Overweight" rating given on Wednesday, February 3 by Piper Jaffray. The firm has "Buy" rating given on Tuesday, November 8 by Mizuho. On Tuesday, May 30 the stock rating was maintained by Maxim Group with "Hold". The stock has "Buy" rating by Jefferies on Wednesday, October 5. The firm has "Hold" rating by Stifel Nicolaus given on Monday, October 31. (NASDAQ:GILD) was sold by Cogan John Francis. On Friday, September 23 the stock rating was upgraded by Raymond James to "Strong Buy". Tru Of Vermont stated it has 0.35% in Gilead Sciences, Inc. The ex-dividend date of this dividend is Wednesday, June 14th. The firm has "Outperform" rating given on Wednesday, July 29 by RBC Capital Markets.

04/24/2017 - Gilead Sciences, Inc. had its "outperform" rating reiterated by analysts at William Blair.

Severe storms for parts of Oklahoma Tuesday
There is a large (yellow) Slight Risk Area that covers pretty much all of Wisconsin, much of IL , large parts of Missouri, E. Thunderstorms will be possible across the rest of south Alabama, but at this time they are not expected to be severe.

Warriors beat Cavaliers to win title
And looking at the Warriors roster, many more could be on the way. After 10 years in the league, Durant finally has a championship.

Biggest announcements from Sony's conference at E3 2017
At E3 2017 , Sony again took to the stage for some more detailed arachnology with a length look at gameplay. Instead, Uncharted spin-off Uncharted: The Lost Legacy was showcased at the E3 conference.

Since January 3, 2017, it had 0 insider purchases, and 11 sales for $33.68 million activity. RBC Capital Markets maintained Gilead Sciences, Inc. Horan Capital Management acquired 73,111 shares as Gilead Sciences Inc (GILD)'s stock declined 8.05%. Also, EVP Gregg H. Alton sold 5,000 shares of Gilead Sciences stock in a transaction dated Thursday, March 30th. WILSON GAYLE E also sold $1.41 million worth of Gilead Sciences, Inc. The EPS of company is strolling at 1.05.The company's Market capitalization is $2.01 Billion with the total Outstanding Shares of 84.23 million. (NYSE:SE) for 13,870 shares. Wal (NYSE:WMT) was reduced too.

According to the the latest analyst ratings which have been released, 5 brokers have issued a rating of "buy", 9 brokers "outperform", 13 brokers "hold", 0 brokers "underperform" and 0 brokers "sell". Earnings, with 20 analysts believing the company would generate an Average Estimate of $2.11. On Friday, April 29 the stock rating was maintained by UBS with "Buy". Bank of America upgraded it to "Neutral" rating and $107 target in Monday, January 18 report. The firm has "Neutral" rating given on Tuesday, August 11 by Goldman Sachs. The company has market cap of $718.53 million. We have $18.50 PT which if reached, will make NASDAQ:SCHN worth $26.46 million less. The company was maintained on Wednesday, September 14 by Credit Suisse. Washington Bank has 0.05% invested in Sempra Energy (NYSE:SRE) for 2,226 shares. Its up 0.13, from 0.95 in 2016Q3. Perigon Wealth Management LLC raised its position in Gilead Sciences by 3.5% in the first quarter. Envestnet Asset Management reported 174,889 shares. Barclays Pcl owns 49,656 shares. Hightower Advsr holds 67,850 shares or 0.01% of its portfolio. Conning owns 0.03% invested in Sempra Energy (NYSE:SRE) for 6,251 shares. Mutual Ins Federation Of Agricultural Cooperatives has 32,000 shares. Timessquare Mgmt owns 5.25 million shares. Wells Fargo Mn has 260,493 shares. Honeywell reported 446,955 shares stake. (NYSE:SE). Moreover, Federated Invsts Pa has 0% invested in Spectra Energy Corp. Goodwin Daniel L bought 5,000 shares as the company's stock declined 8.05% while stock markets rallied. Citigroup Incorporated stated it has 0.1% of its portfolio in Apollo Global Management LLC (NYSE:APO).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by GizPress

Discuss This Article